FDA Finds Quality Documents Stuck in a Shredder at Glenmark Facility
By Zachary Brennan -
Published 05 December 2017
The US Food and Drug Administration (FDA) on Tuesday released a heavily redacted Form 483 sent last month to Glenmark Pharmaceuticals' Solan, India-based manufacturing facility.
Categories: News, US, FDA, Crisis management, Drugs, Ethics, Regulatory strategy
Tags: Glenmark Pharmaceuticals, Form 483